Cowgills advised the shareholders of Macclesfield based bioanalytical Contract Research Organisation (CRO) Alderley Analytical Ltd on their sale to Dutch based Synexa Life Sciences, a portfolio business of Gilde Healthcare.
About the company
Alderley Analytical is an independent Contract Research Organisation (CRO). Specialising in bioanalytical services to support drug development programmes through discovery, pre-clinical safety testing and clinical development.
About the deal
Cowgills provided sell side Corporate Finance advisory services to the shareholders of Alderley Analytical on their sale to Dutch based Synexa Life Sciences, a portfolio business of Gilde Healthcare.
The acquisition is part of Synexa’s ‘buy and build’ growth strategy, driven by the company’s vision to become ‘the scientific partner of choice for biomarker and bioanalytical solutions’.
The transaction represented an exit for investor groups River Capital and Alderley Park Ventures.
Sector
Healthcare
Cowgills services provided
Sell-side lead advisory
